• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁螯合疗法逆转青少年血色素沉着症终末期心力衰竭:一例报告

Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.

作者信息

Cooray Shamil D, Heerasing Neel M, Selkrig Laura A, Subramaniam V Nathan, Hamblin P Shane, McDonald Cameron J, McLean Catriona A, McNamara Elissa, Leet Angeline S, Roberts Stuart K

机构信息

Department of Endocrinology & Diabetes, The Alfred Hospital, Melbourne, VIC, 3004, Australia.

Department of Gastroenterology & Hepatology, The Alfred Hospital, Melbourne, VIC, 3004, Australia.

出版信息

J Med Case Rep. 2018 Jan 26;12(1):18. doi: 10.1186/s13256-017-1526-6.

DOI:10.1186/s13256-017-1526-6
PMID:29373985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787235/
Abstract

BACKGROUND

Juvenile hemochromatosis is the most severe form of iron overloading phenotype. Although rare, it should be suspected in patients who present with hypogonadotropic hypogonadism, diabetes mellitus, or cardiomyopathy without a clear cause.

CASE PRESENTATION

A young Serbian male presenting with end-stage heart failure was referred for extracorporeal membrane oxygenation. An endomyocardial biopsy revealed cytoplasmic iron deposits in myocytes. His condition was stabilized with biventricular assist devices and he was listed for heart transplantation. Iron chelation therapy was commenced and resulted in rapid removal of iron burden. Serial outpatient echocardiograms demonstrated myocardial recovery such that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a loss-of-function mutation within the HJV gene, which is consistent with juvenile hemochromatosis.

CONCLUSIONS

This rare case of a patient with juvenile hemochromatosis associated with a HJV mutation provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory support, with iron chelation therapy.

摘要

背景

青少年血色病是铁过载表型最严重的形式。尽管罕见,但对于出现不明原因的低促性腺激素性性腺功能减退、糖尿病或心肌病的患者应怀疑此病。

病例介绍

一名出现终末期心力衰竭的年轻塞尔维亚男性被转诊接受体外膜肺氧合治疗。心内膜心肌活检显示心肌细胞中有细胞质铁沉积。通过双心室辅助装置使他的病情稳定下来,他被列入心脏移植名单。开始进行铁螯合治疗,铁负荷迅速减轻。系列门诊超声心动图显示心肌恢复,以至于在初次植入双心室辅助装置131天后成功将其取出。靶向基因测序显示HJV基因存在功能丧失突变,这与青少年血色病一致。

结论

这例罕见的与HJV突变相关的青少年血色病患者病例提供了组织学证据,证明铁螯合疗法可逆转相关的终末期心力衰竭,而这种心力衰竭需要紧急机械循环支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e7/5787235/df0e25d7cc47/13256_2017_1526_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e7/5787235/df0e25d7cc47/13256_2017_1526_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e7/5787235/df0e25d7cc47/13256_2017_1526_Fig1_HTML.jpg

相似文献

1
Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.铁螯合疗法逆转青少年血色素沉着症终末期心力衰竭:一例报告
J Med Case Rep. 2018 Jan 26;12(1):18. doi: 10.1186/s13256-017-1526-6.
2
Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).去铁酮和去铁胺联合治疗对一名重症青少年血色素沉着症(JH)患者心脏并发症的逆转作用
Blood. 2007 Jan 1;109(1):362-4. doi: 10.1182/blood-2006-04-016949. Epub 2006 Sep 7.
3
Cardiac Hemochromatosis Treated With Prolonged Extracorporeal Membrane Oxygenation Support and Chelation Therapy.
Artif Organs. 2018 May;42(5):575-576. doi: 10.1111/aor.13076.
4
[Hereditary hemochromatosis].[遗传性血色素沉着症]
Rev Gastroenterol Peru. 2001 Jan-Mar;21(1):42-55.
5
Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis.一名患有继发性血色素沉着症的严重再生障碍性贫血患者在接受持续铁螯合治疗后实现了完全造血恢复。
J Korean Med Sci. 2008 Apr;23(2):320-3. doi: 10.3346/jkms.2008.23.2.320.
6
Novel Mutation in the Hemojuvelin Gene (HJV) in a Patient with Juvenile Hemochromatosis Presenting with Insulin-dependent Diabetes Mellitus, Secondary Hypothyroidism and Hypogonadism.血影蛋白基因(HJV)新突变致青少年血色病伴发胰岛素依赖型糖尿病、继发性甲状腺功能减退和性腺功能减退
Am J Case Rep. 2020 Apr 24;21:e923108. doi: 10.12659/AJCR.923108.
7
Type 3 hemochromatosis and beta-thalassemia trait.3型血色素沉着症和β地中海贫血特质。
Eur J Haematol. 2004 May;72(5):370-4. doi: 10.1111/j.1600-0609.2004.00230.x.
8
An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis.一种铁螯合剂改善了遗传性血色素沉着症所致严重心力衰竭患者的心脏功能。
Intern Med. 2024 Jan 15;63(2):253-258. doi: 10.2169/internalmedicine.1809-23. Epub 2023 May 17.
9
Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
Haematologica. 2000 Aug;85(8):865-7.
10
Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease.遗传性青少年血色素沉着症:一种具有遗传异质性的危及生命的铁储存疾病。
QJM. 1998 Sep;91(9):607-18. doi: 10.1093/qjmed/91.9.607.

引用本文的文献

1
The Quiet Burden of Iron: A Rare Case of Hereditary Hemochromatosis in Pakistan.铁的隐匿负担:巴基斯坦一例罕见的遗传性血色素沉着症病例
Cureus. 2025 Jul 20;17(7):e88355. doi: 10.7759/cureus.88355. eCollection 2025 Jul.
2
Diagnosis and Management of Non-HFE Hemochromatosis, Ferroportin Disease, and Rare Hereditary Iron-Loading Disorders.非HFE型血色素沉着症、铁转运蛋白病及罕见遗传性铁过载疾病的诊断与管理
Adv Exp Med Biol. 2025;1480:131-143. doi: 10.1007/978-3-031-92033-2_10.
3
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation.

本文引用的文献

1
The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.根据对下一代测序数据的分析估计的HFE和非HFE血色素沉着症的全球患病率。
Genet Med. 2016 Jun;18(6):618-26. doi: 10.1038/gim.2015.140. Epub 2015 Dec 3.
2
Interpreting raised serum ferritin levels.解读血清铁蛋白水平升高
BMJ. 2015 Aug 3;351:h3692. doi: 10.1136/bmj.h3692.
3
Next-generation sequencing: Application of a novel platform to analyze atypical iron disorders.下一代测序:新型平台在分析非典型铁代谢紊乱中的应用。
遗传性血色素沉着症的诊断与管理:生活方式调整、放血疗法及献血
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):434-442. doi: 10.1182/hematology.2024000568.
4
An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis.一种铁螯合剂改善了遗传性血色素沉着症所致严重心力衰竭患者的心脏功能。
Intern Med. 2024 Jan 15;63(2):253-258. doi: 10.2169/internalmedicine.1809-23. Epub 2023 May 17.
5
Hepcidin and Iron in Health and Disease.《健康与疾病中的铁调素与铁》
Annu Rev Med. 2023 Jan 27;74:261-277. doi: 10.1146/annurev-med-043021-032816. Epub 2022 Jul 29.
6
Juvenile Hemochromatosis due to a Homozygous Variant in the Gene.因该基因纯合变异导致的青少年血色素沉着症。
Case Rep Pediatr. 2022 Apr 11;2022:7743748. doi: 10.1155/2022/7743748. eCollection 2022.
7
Hidden in Heart Failure.隐匿于心力衰竭之中。
Eur Cardiol. 2019 Jul 11;14(2):89-96. doi: 10.15420/ecr.2019.19.2. eCollection 2019 Jul.
8
Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.原发性血色病患者血幼素基因突变的基因型和表型谱:系统评价。
Orphanet J Rare Dis. 2019 Jul 8;14(1):171. doi: 10.1186/s13023-019-1097-2.
J Hepatol. 2015 Nov;63(5):1288-93. doi: 10.1016/j.jhep.2015.06.027. Epub 2015 Jul 4.
4
Guidelines for quantifying iron overload.铁过载定量指南。
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):210-5. doi: 10.1182/asheducation-2014.1.210. Epub 2014 Nov 18.
5
Marked hyperferritinemia does not predict for HLH in the adult population.显著的高血铁蛋白血症不能预测成人 HLH。
Blood. 2015 Mar 5;125(10):1548-52. doi: 10.1182/blood-2014-10-602607. Epub 2015 Jan 8.
6
Oral deferiprone for iron chelation in people with thalassaemia.口服去铁酮用于地中海贫血患者的铁螯合治疗。
Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004839. doi: 10.1002/14651858.CD004839.pub3.
7
Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations.亚太人群铁储存疾病:非 HFE 突变的重要性。
J Gastroenterol Hepatol. 2013 Jul;28(7):1087-94. doi: 10.1111/jgh.12222.
8
Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.不同铁螯合方案对重型地中海贫血患者心脏铁去除和心功能改善的作用。
Ann Hematol. 2012 Sep;91(9):1443-9. doi: 10.1007/s00277-012-1480-8. Epub 2012 May 10.
9
Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.接受地拉罗司铁螯合治疗的血色素沉着症相关铁过载:肝脏疾病活动度、心脏及血液学功能的改善
Eur J Haematol. 2011 Nov;87(5):467-9. doi: 10.1111/j.1600-0609.2011.01693.x. Epub 2011 Oct 2.
10
A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation.一种诊断高血铁蛋白伴非增高转铁饱和度的方法。
J Hepatol. 2011 Aug;55(2):453-8. doi: 10.1016/j.jhep.2011.02.010. Epub 2011 Feb 24.